A Study to Evaluate Raptiva in Adults With Plaque Psoriasis Previously Enrolled in Study ACD2390g
NCT00109252
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
INDUSTRY
Sponsor class
Conditions
Psoriasis
Interventions
DRUG:
Raptiva (efalizumab)
Sponsor
Genentech, Inc.